Molecular mechanism of diallyl disulfide in cell cycle arrest and apoptosis in HCT-116 colon cancer cells

J Biochem Mol Toxicol. 2009 Jan-Feb;23(1):71-9. doi: 10.1002/jbt.20266.

Abstract

Diallyl disulfide (DADS) is the most prevalent oil-soluble sulfur compound in garlic and inhibits cell proliferation in many cancer cell lines. Here we examined DADS cytotoxicity in a redox-mediated process, involving reactive oxygen species (ROS) production. In the present study, p53-independent cell cycle arrest at G2/M phase was observed with DADS treatment, along with time-dependent increase of cyclin B1. In addition, apoptosis was also observed upon 24-h DADS treatment accompanied by activation of p53. In HCT-116 cells, DADS application induced a dose-dependent increase and time-dependent changes in ROS production. Scavenging of DADS-induced ROS by N-acetyl cysteine or reduced glutathione inhibited cell cycle arrest, apoptosis and p53 activation by DADS. These results suggest that ROS trigger the DADS-induced cell cycle arrest and apoptosis and that ROS are involved in stress-induced signaling upstream of p53 activation. Transfection of p53 small interfering RNA prevents the accumulation of cleaved poly(ADP-ribose) polymerase and sub-G1 cell population by 65% and 35%, respectively. Moreover, DADS-induced apoptosis was also prevented by treatment with oligomycin, which is known to prevent p53-dependent apoptosis by reducing ROS levels in mitochondria. These results suggest that mitochondrial ROS may serve as second messengers in DADS-induced apoptosis, which requires activation of p53.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allyl Compounds / pharmacology*
  • Antioxidants / metabolism
  • Apoptosis / drug effects*
  • CDC2 Protein Kinase / metabolism
  • Cell Cycle / drug effects*
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Colonic Neoplasms / pathology*
  • Cyclin B / metabolism
  • Cyclin B1
  • Disulfides / pharmacology*
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Flow Cytometry
  • HCT116 Cells
  • Humans
  • Oligomycins / pharmacology
  • Poly(ADP-ribose) Polymerases / metabolism
  • RNA, Small Interfering / metabolism
  • Reactive Oxygen Species / metabolism
  • Time Factors
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Allyl Compounds
  • Antioxidants
  • CCNB1 protein, human
  • Cyclin B
  • Cyclin B1
  • Disulfides
  • Oligomycins
  • RNA, Small Interfering
  • Reactive Oxygen Species
  • Tumor Suppressor Protein p53
  • diallyl disulfide
  • Poly(ADP-ribose) Polymerases
  • CDC2 Protein Kinase